Long-term management of the liver transplant recipient

Medical Clinics of North America

Volumn 80, Issue 5, 1996, Pages 1103-1120

  Munoz, S J ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; AZATHIOPRINE; COLESTYRAMINE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOSPORIN A; DANAZOL; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; HEPATITIS B VACCINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; KETOCONAZOLE; METHYLPREDNISOLONE; METOCLOPRAMIDE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICARDIPINE; NICOTINIC ACID; OKT 3; PREDNISONE; PROBUCOL; RIFAMPICIN; TACROLIMUS; UNINDEXED DRUG; VARICELLA ZOSTER VACCINE; VERAPAMIL;

ANTIBIOTIC PROPHYLAXIS; CANCER SCREENING; CORONARY ARTERY DISEASE; GRAFT REJECTION; HEPATITIS B; HUMAN; HYPERLIPIDEMIA; IMMUNIZATION; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; LONG TERM CARE; NEPHROTOXICITY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; REVIEW;

EID: 0029782006     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70481-8     Document Type: Article

References (72)

1. American College of Physicians Task Force on Adult Immunization Guide for Adult Immunization ed 3 1994 American College of Physicians Philadelphia
2. A. Anand S. Hubscher B. Gunson Timing, significance and prognosis of late acute liver allograft rejection Transplantation 60 1995 1098
3. V. Armenti J. Radomski M. Moritz Parenthood after liver transplantation Liver Transpl Surg 1 suppl 1 1995 84
4. R. Ayres T. Ismail L. Angrisani Long term renal function in liver transplantation Transpl Proc 23 1991 1469
5. G. Baumgardner J. Roberts New immunosuppressive agents Gastroenterol Clin North Am 22 1993 421
6. M. Berenguer N. Terrault M. Piatak Hepatitis G virus in hepatitis C virus infection following liver transplantation Hepatology 22 1995 151A
7. T. Beresford J. Schwartz D. Wilson The short term psychological health of alcoholic and non-alcoholic liver transplant recipients Alcohol Clin Exp Res 16 1992 996
8. G. Bird J. O'Grady F. Harvey Liver transplantation in patients with alcoholic cirrhosis: Selection criteria and rates of survival and relapse BMJ 301 1990 15
9. U. Broome R. Lofberg B. Vereness Primary sclerosing cholangitis and ulcerative colitis: Evidence for increased neoplastic potential Hepatology 22 1995 1404
10. D. Bronster M. Lidov D. Wolfe Progressive multifocal leukoencephalopathy after orthotopic liver transplantation Liver Transplant Surg 1 1995 371
11. R. Calne D. White S. Thiru Cyclosporin A in patients receiving renal allografts from cadaver donors Lancet 2 1978 1323
12. H. Cen P. Williams H. McWilliams Evidence for restricted Epstein-Barr virus latent gene expression and anti-EBNA antibody response in solid organ transplant recipients with post-transplant lymphoproliferative disorders Blood 81 1993 1393
13. Centers for Disease Control Recommendations of the Advisory Committee on Immunizations Practices: Use of vaccines and immune globulins in persons with altered immunocompetence MMWR 42 RR-2 1993 1
14. R. Clemens A. Safary A. Hepburn Clinical experience with an inactivated hepatitis A vaccine J Infect Dis 171 suppl 1 1995 S44
15. J. Colonna D. Winston J. Brill Infectious complications in liver transplantation Arch Surg 123 1988 360
16. C. Corpier P. Jones W. Suki Rhabdomyolysis and renal injury with lovastatin use: Report of two cases in cardiac transplant recipients JAMA 260 1988 239
17. A. Di Bisceglie Liver transplantation for hepatitis C: The promise and the challenge Hepatology 22 1995 660
18. C. Duvoux J. Pawlotsky D. Cherqui Serial quantitative determination of hepatitis C virus RNA levels after liver transplantation Transplantation 60 1995 475
19. European FK506 Multicenter Study Group Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection Lancet 344 1994 423
20. R. Evans Social, vocational and financial consequences of liver transplantation Liver Transplant Surg 1 suppl 1 1995 116
21. S. Fagiuoli G. Shah H. Wright Types, causes, and therapies of hepatitis occurring in liver transplant recipients Dig Dis Sci 38 1993 449
22. C. Friese M. Herbert R. Osorio Maintenance immunosuppression with prednisone and RS-6144 alone following liver transplantation Transpl Proc 25 1993 1758
23. J. Fung J. Rakela A. Pinna Liver transplantation for hepatitis B: What have we learned and what does the future hold? Liver Transpl Surg 1 1995 274
24. T. Gonwa C. Morris R. Goldstein Long term survival and renal function following liver transplantation in patients with and without hepatorenal syndrome—experience in 300 patients Transplantation 51 1991 428
25. N. Grace Liver transplantation for hemochromatosis: An ironic dilemma Liver Transpl Surg 1 1995 234
26. T. Gunning M. Brown T. Swygert Perioperative renal function in patients undergoing orthotopic liver transplantation: A randomized trial of the effects of verapamil Transplantation 51 1991 422
27. J.E. Hay Bone disease after liver transplantation Liver Transplant Surg 1 suppl 1 1995 55
28. H. Higashi K. Yanaga J. Marsh Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis Hepatology 11 1990 477
29. L. Judd K.T. Britton D.L. Braff Mental disorders K. Isselbacher E. Braunwald J. Wilson Principles of Internal Medicine 1994 McGraw-Hill New York 2400 2419
30. D. Kenagy Y. Schlesinger K. Weck Epstein-Barr virus DNA in peripheral blood leukocytes of patients with post transplant lymphoproliferative disease Transplantation 60 1995 547
31. E. Kieff Epstein-Barr virus: Increasing evidence of a link to carcinoma N Engl J Med 333 1995 724
32. I. Kitai S. King A. Gafni An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients Clin Infect Dis 17 1993 441
33. G. Klintmalm T. Gonwa Nephrotoxicity associated with cyclosporine and FK506 Liver Transpl Surg 1 suppl 1 1995 11
34. G. Klintmalm S. Iwatsuki T. Starzl Nephrotoxicity of cyclosporine A in liver and kidney transplant recipients Lancet 2 1981 470
35. S. Kumar R. Stauber J. Gavaler Orthotopic liver transplantation for alcoholic liver disease Hepatology 11 1990 159
36. S. Kusne J. Dummer N. Singh Infections after liver transplantation Medicine 67 1988 132
37. E. Lee J. Locker M. Nalesnick The association of Epstein-Barr virus with smooth muscle tumors occurring after organ transplantation N Engl J Med 332 1995 19
38. R. Levitz B. Cooper H. Regan Immunization with high-dose intradermal recombinant hepatitis B vaccine in healthcare workers who failed to respond to intramuscular vaccination Infect Cont Hosp Epidemiol 16 1995 88
39. K. Lin L. Rocker M. McQuillan Cyclosporin-induced hyperuricemia and gout N Engl J Med 321 1989 287
40. M. Lucey Neurological and psychiatric complications associated with immunosuppression in liver transplantation Liver Transplant Surg 1 suppl 1 1995 39
41. R. Markin R. Stratta P. Woods Infections after liver transplantation Am J Surg Pathol 14 suppl 1 1990 64
42. D. Mayfield G. Macleod P. Hall The CAGE questionnaire: Validation of a new alcohol screening instrument Am J Psychiatry 31 1974 1121
43. S. McDiarmid R. Ettenger R. Hawkins The impairment of true glomerular filtration rate in long-term cyclosporin-treated pediatric allograft recipients Transplantation 49 1990 81
44. F. Menegaux E. Keefe B. Andrews Neurological complications of liver transplantation in adults versus pediatric recipients Transplantation 58 1994 447
45. J. Millis S. McDiarmid J. Hiatt Randomized prospective trial of OKT3 for early prophylaxis of rejection after liver transplantation Transplantation 47 1989 82
46. E. Mueller Z. Kallay J. Kovarik Bile-independent absorption of cyclosporine from a microemulsion formulation in liver transplant patients Transplantation 60 1995 515
47. S. Muñoz Hyperlipidemia and other coronary risk factors after orthotopic liver transplantation: Pathogenesis, diagnosis, and management Liver Transplant Surg 1 suppl 1 1995 29
48. S. Muñoz R. Deems M. Moritz Hyperlipidemia and obesity after orthotopic liver transplantation Transpl Proc 23 1991 1480
49. Muñoz S, Westerberg S: Liver transplantation in adults: Medical considerations. In Kassirer J, Greene H (eds): Current Therapy in Internal Medicine. Philadelphia, Mosby-Year Book, in press
50. I. Nagafuchi S. Kashiwagi K. Okada Reversal of nonresponders and postexposure prophylaxis by intradermal hepatitis B vaccination in Japanese medical personnel JAMA 265 1991 2679
51. National Transplantation Pregnancy Registry Analysis of pregnancy outcomes in female liver transplant recipients Liver Transpl Surg 1 1995 281
52. R. Osorio N. Ascher M. Avery Predicting recidivism after orthotopic liver transplantation for alcoholic liver disease Hepatology 20 1994 105
53. J. Palazzo K. Lundquist D. Mitchell Rapid development of lymphoma following liver transplantation in a recipient with hepatitis B and primary hemochromatosis Am J Gastroenterol 88 1993 102
54. I. Penn Cancer complicating organ transplantation N Engl J Med 323 1990 1767
55. J. Radomski M. Moritz V. Armenti Hepatitis B transmission from a liver donor negative for hepatitis B surface antigen and positive for hepatitis B core antibody Liver Transpl Surg 2 1996 130
56. R.H. Rubin Infectious disease problems W.C. Maddrey M.F. Sorrell Transplantation of the Liver 1994 Appleton & Lange Norwalk, CT 367 398
57. D. Samuel R. Muller G. Alexander Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1993 1842
58. E. Schiff Liver transplantation for hepatitis B Liver Transpl Surg 1 1995 259
59. S. Sherman P. Jamidar A. Shaked Biliary tract complications after orthotopic liver transplantation Transplantation 60 1995 467
60. H. Sollinger the U.S. Renal Transplantation Mycophenolate Mofetil Study Group Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients Transplantation 60 1995 225
61. M. Stegall G. Everson G. Schroter Metabolic complications after liver transplantation: Diabetes, hypercholesterolemia, hypertension and obesity Transplantation 60 1995 1057
62. L. Swinnen M. Costanzo-Nordin S. Fischer Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients N Engl J Med 323 1990 1723
63. S. Textor De-novo hypertension after liver transplantation Hypertension 22 1993 257
64. K. Trail R. Stratta J. Larsen Orthotopic hepatic transplantation in patients with type I diabetes mellitus J Am Coll Surg 178 1994 337
65. U.S. Multicenter FK506 Liver Study Group A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation N Engl J Med 331 1994 1110
66. J. Wade N. Rolando K. Hayllar Bacterial and fungal infections after liver transplantation: An analysis of 284 patients Hepatology 21 1995 1328
67. J. Wahlberg H. Wilczek P. Fauchald Consistent absorption of cyclosporin from a microemulsion formulation accessed in stable renal transplant recipients over a study period of one year Transplantation 60 1995 648
68. H. Wheatley M. Datzman J. Williams Long term effects of cyclosporine on renal function in liver transplant patients Transplantation 43 1987 641
69. D. Winston C. Emmanouilides R. Busuttil Infections in liver transplant recipients Clin Infect Dis 21 1995 1077
70. S.H. Woolf Screening for prostate cancer with prostate-specific antigen: An examination of the evidence N Engl J Med 333 1995 1401
71. T. Wright Liver transplantation for chronic hepatitis C viral infection Gastroenterol Clin North Am 22 1993 231
72. N. Zein J. Rakela J. Poterucha Hepatitis C genotypes in liver transplant recipients: Distribution and 1-year follow up Liver Transpl Surg 1 1995 354